高级检索

乳腺癌新辅助化疗的意义及其应用

张斌

张斌. 乳腺癌新辅助化疗的意义及其应用[J]. 实用临床医药杂志, 2003, (2): 112-114. DOI: 10.3969/j.issn.1672-2353.2003.02.005
引用本文: 张斌. 乳腺癌新辅助化疗的意义及其应用[J]. 实用临床医药杂志, 2003, (2): 112-114. DOI: 10.3969/j.issn.1672-2353.2003.02.005
shu
The significance of neoadujvant chemotherapy on breast cancers[J]. Journal of Clinical Medicine in Practice, 2003, (2): 112-114. DOI: 10.3969/j.issn.1672-2353.2003.02.005
Citation: The significance of neoadujvant chemotherapy on breast cancers[J]. Journal of Clinical Medicine in Practice, 2003, (2): 112-114. DOI: 10.3969/j.issn.1672-2353.2003.02.005
shu

乳腺癌新辅助化疗的意义及其应用

  • 辽宁省肿瘤医院乳腺科,沈阳,110042

详细信息

  • 中图分类号: R737.9

The significance of neoadujvant chemotherapy on breast cancers

摘要

    摘要
  • 摘要: 乳腺癌易于发生血行播散,即使是“早期”癌,常已存在周身的亚临床转移,故认为乳腺癌为一全身性疾病之称.自20世纪70年代,人们逐渐加强了乳腺癌的全身治疗(主要是化疗,或加内分泌治疗),患者的生存率明显提高,生存质量也有改善,化疗便成为……
    • HTML全文
    • 参考文献(10)
  • Fisher B, Bryant J, Wolmark N. Effeet of pre-operative chemotherapy on the outcome of women with operable breast cancer [J]. Journal of Clinical Oncology, 1998.2672.
    Mauriae L, Mac Grogsn G, Avril A. Neoadjuvant chernotherapy For operable breast carcinoma larger than 3 cm:A unicentre randomized trial with 124-month median follow-up [J]. Annals of Oncology, 1999, (1):47.doi: 10.1023/A:1008337009350.
    Broet P, Shooll S M, De la Rochefordiere A. Short and long term effects on survival in breast cancer patients treated by primary chemotherapy: An updated analysis of a randomized trial [J]. Breast Cancer Research and Treatment, 1999.151.doi: 10.1023/A:1006339918798.
    Bonadonna G, Valagussa P, Brambilla C. chemotherapy in operable breast cancer: Eight-year experience at the Milan Cancer Institute [J]. Journal of Clinical Oncology, 1998.93.
    Jos A, van der Hage, Comelis J H, van de Velde,. Preoperative chemotherapy in primary operable breast cancer: Results from the European organization for research and treatment of cancer trial 10902 [J]. Journal of Clinical Oncology, 2001.4224.
    CANCE W G, Carey L A, Calvo B F. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma:effective chnical downstaging allows breast preservation and predicts outstanding local control and survival [J]. Annals of Surgery, 2002(3):295.doi: 10.1097/00000658-200209000-00006.
    Bonadonna G, Valagussa P, Brambilla C. Adjuvant and neoadjuvant treatment of breast cancer with chemotherapy and/or endocrine therapy [J]. Seminars in Oncology, 1991(6):515.
    Bhalla K, Harris W B. Molecular and biologic determinants of neoedjuvant chemotherapy of locoregional breast cancer [J]. Seminars in Oncology, 1998(3):19.
    张斌, 蔡玉娥, 张齐. 新辅助化疗用于可手术乳腺癌的10年疗效 [J]. 中国肿瘤临床, 2002(3):157.doi: 10.3969/j.issn.1000-8179.2002.03.002.
    Hutcheon A W, Heys S D, Miller I D. Improvement in survival in patients receiving primary chemotherapy with docetaxel for breast cancer: a randomized controlled trial [J]. Breast Cancer Research and Treatment, 2001(3):298.
    • 相关文章
    • 施引文献
    • 资源附件(0)
计量
  • 文章访问数:  168
  • HTML全文浏览量:  46
  • PDF下载量:  16
  • 被引次数: 0
出版历程
  • 发布日期:  2004-07-30

目录

摘要
HTML全文
    参考文献(10)
    相关文章
    施引文献
    资源附件(0)

    /

    返回文章
    返回

    © 2020 《实用临床医药杂志》编辑部

    地址：江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室邮编：225009电话：0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    本系统由 北京仁和汇智信息技术有限公司 开发  百度统计

    x 关闭 永久关闭